Search results for "Hypertensive"

showing 10 items of 250 documents

Dietary (n-3) polyunsaturated fatty acids exert antihypertensive effects by modulating calcium signaling in T cells of rats.

2001

After 10 wk of feeding an experimental diet enriched with (n-3) polyunsaturated fatty acids (PUFA), i.e., eicosapentaenoic acid [EPA, 20:5(n-3)] and [DHA, 22:6(n-3)] (EPAX), blood pressure in spontaneously hypertensive rats (SHR), but not in normotensive Wistar-Kyoto (WKY) rats was reduced relative to rats fed an unsupplemented control diet. Concanavalin A-stimulated T-cell proliferation was diminished in both strains of rats fed the PUFA/EPAX diet. The experimental diet lowered secretion of interleukin-2 in SHR, but not in WKY rats compared with rats fed the control diet. To determine whether there was a defect in calcium homeostasis in T cells during hypertension, we employed the followin…

Malemedicine.medical_specialtyThapsigarginT-LymphocytesMedicine (miscellaneous)chemistry.chemical_elementCalciumBiologyBinding CompetitiveRats Inbred WKYchemistry.chemical_compoundAldesleukinInternal medicineFatty Acids Omega-6Rats Inbred SHRFatty Acids Omega-3medicineAnimalsCalcium SignalingUnsaturated fatty acidAntihypertensive AgentsPhospholipidsCalcium metabolismchemistry.chemical_classificationImmunosuppression TherapyNutrition and DieteticsVoltage-dependent calcium channelIntracellular MembranesEicosapentaenoic acidDietary FatsRatsEndocrinologychemistryFatty Acids Unsaturatedlipids (amino acids peptides and proteins)Polyunsaturated fatty acidThe Journal of nutrition
researchProduct

Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics an…

2020

Background: Different studies have indicated that thiazide diuretics can increase the risk of developing type 2 diabetes (T2D). Therefore, in this study, we investigated whether switching from hydrochlorothiazide (HCTZ) to amlodipine resulted in ameliorating different cardiovascular and metabolic measures in hypertensive patients with or without T2D. Methods: This study [Diuretics and Diabetes Control (DiaDiC)] was a 6-week, single-blind, single-center randomized controlled trial. The first 20 normal glucose-tolerant, 20 prediabetic, and 20 T2D consecutive patients were randomized to continue the previous antihypertensive treatment with HCTZ (12.5-25 mg/day) or to switch from HCTZ to amlodi…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismSodium Chloride Symporter InhibitorsdiureticBlood PressureType 2 diabetesSettore MED/13 - EndocrinologiaInternal medicineInternal MedicineMedicineHumansSingle-Blind MethodAmlodipineSettore MED/49 - Scienze Tecniche Dietetiche ApplicateThiazideAntihypertensive AgentsAgedtreatmentbusiness.industryDrug Substitutioncardiovascularfood and beveragesMiddle Agedmedicine.diseaseCalcium Channel BlockersDiabetes controlHydrochlorothiazideTreatment OutcomeDiabetes Mellitus Type 2ItalyHypertensionCardiologyFemaletype 2 diabetesAmlodipinethiazidebusinessEnergy MetabolismmetabolismBiomarkersmedicine.drugMetabolic syndrome and related disorders
researchProduct

Differences in blood pressure control and stroke mortality across Spain: the Prevención de Riesgo de Ictus (PREV-ICTUS) study.

2007

The objective was to assess the stroke risk and prevalence of the cardiovascular risk factors and to analyze their relationship with the specific stroke rates of mortality in each of the autonomic communities of Spain. We conducted a multicenter, cross-sectional study of population >60 years old in Spanish primary care centers. In all of the subjects, clinical, biochemical, and electrocardiographic data were obtained, and the 10-year stroke risk was calculated using the Framingham score. Mortality rates of stroke, age and sex adjusted, were obtained for each of the autonomic communities from the Ministry of Health. A total of 7343 subjects (mean age: 71.6 years, 53.4% women, 34.4% obese…

Malemedicine.medical_specialtyTime FactorsPopulationBlood PressureRisk AssessmentRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicinePrevalenceHumanscardiovascular diseasesRisk factoreducationStrokeAntihypertensive AgentsAgededucation.field_of_studyFramingham Risk ScoreVascular diseasebusiness.industryMortality ratemedicine.diseaseSurgeryStrokeBlood pressureCross-Sectional StudiesTreatment OutcomeSpainHypertensionFemaleHypertrophy Left VentricularbusinessHypertension (Dallas, Tex. : 1979)
researchProduct

Effects of the flavonoids extracted from Spergularia purpurea Pers. on arterial blood pressure and renal function in normal and hypertensive rats

2001

The antihypertensive and diuretic effects of the flavonoids extracted from Spergularia purpurea Pers. (SP) were studied both in normotensive (NTR) and spontaneously hypertensive conscious rats (SHR). Daily oral administration of the flavonoid mixture (5 mg/kg for 1 week) exhibited a significant decrease in blood pressure with variation coefficient (Delta) of 20 in SHR rats and 11 in NTR rats. The systolic and diastolic blood pressure decreased significantly and respectively with 17 and 24% in SHR, and with 11 and 16% in NTR. The flavonoid mixture enhanced significantly the water excretion in hypertensive (P<0.001) and normal rats (P<0.001). Furthermore, oral administration of flavonoids mix…

Malemedicine.medical_specialtyUrinary systemmedicine.medical_treatmentAdministration OralRenal functionBlood PressureKidneyKidney Function Testslaw.inventionOral administrationlawRats Inbred SHRInternal medicineDrug DiscoveryHeart ratemedicineAnimalsRats WistarDiureticsAntihypertensive AgentsFlavonoidsPharmacologybiologyPlant Extractsbusiness.industryfood and beveragesbiology.organism_classificationRatsBlood pressureEndocrinologyHypertensionDiureticPhytotherapybusinessSpergulariaJournal of Ethnopharmacology
researchProduct

Fine Structural Evaluation of the Iris After Unilateral Treatment With Latanoprost in Patients Undergoing Bilateral Trabeculectomy (The Mainz II Stud…

2003

Objective To investigate by masked electron microscopy whether 6 months of topical latanoprost caused pathological changes in the peripheral iris of patients with glaucoma. Methods Seventeen patients with bilateral primary open-angle glaucoma requiring trabeculectomy were recruited for this study. The iridectomy taken during surgery on the first eye served as a control. The second test eye was treated topically with latanoprost for 6 months before its trabeculectomy. Fourteen patients completed the treatment arm of the study, and 1 of these underwent marked color change. As a result, 31 iridectomy specimens were fixed, coded, and evaluated. Results The specimens were evaluated for evidence …

Malemedicine.medical_specialtygenetic structuresAdministration Topicalmedicine.medical_treatmentEye diseaseIrisGlaucomaTrabeculectomyMelanocyteExfoliation Syndromechemistry.chemical_compoundDouble-Blind MethodOphthalmologymedicineHumansTrabeculectomyIris (anatomy)LatanoprostAntihypertensive AgentsAgedMelaninsbusiness.industryEye dropMiddle Agedmedicine.diseaseeye diseasesOphthalmologymedicine.anatomical_structurechemistryIridectomyProstaglandins F SyntheticLatanoprostMelanocytesFemalesense organsbusinessGlaucoma Open-AngleArchives of Ophthalmology
researchProduct

Effectiveness and Tolerability of Fixed-Dose Combination Enalapril plus Nitrendipine in Hypertensive Patients Results of the 3-Month Observational, P…

2009

Background and objective: Monotherapy with any class of antihypertensive drug effectively controls blood pressure (BP) in only about 50% of patients. Consequently, the majority of patients with hypertension require combined therapy with two or more medications. This study aimed to evaluate the effectiveness (systolic BP [SBP]/diastolic BP [DBP] control) and tolerability of the fixed-dose combination enalapril/nitrendipine 10 mg/20 mg administered as a single daily dose in hypertensive patients. Methods: This was a post-authorization, multicentre, prospective, observational study conducted in primary care with a 3-month follow-up. Patients throughout Spain with uncontrolled hypertension (>= …

Malemedicine.medical_specialtymedicine.drug_classSystolic hypertensionFixed-dose combinationPopulationAngiotensin-Converting Enzyme InhibitorsBlood PressureEssential hypertensionEnalaprilInternal medicinemedicineProduct Surveillance PostmarketingHumansPharmacology (medical)EnalaprilProspective StudieseducationAntihypertensive drugAntihypertensive Agentseducation.field_of_studyDose-Response Relationship DrugPrimary Health Carebusiness.industryNitrendipineGeneral MedicineMiddle Agedmedicine.diseaseCalcium Channel BlockersDrug CombinationsBlood pressureTolerabilityAnesthesiaHypertensionFemalebusinessmedicine.drug
researchProduct

Prevalence of Uncontrolled Hypertension in Patients With Fabry Disease

2017

Background Fabry disease is a rare X-linked disease arising from deficiency of α-galactosidase A. It results in early death related to renal, cardiac, and cerebrovascular disease, which are also important outcomes in patients with elevated blood pressure (BP). The prevalence of uncontrolled hypertension, as well as the effect of enzyme replacement therapy on BP, in patients with Fabry disease is unknown. Methods We examined uncontrolled hypertension (systolic BP [SBP] ≥130 mm Hg or diastolic BP [DBP] ≥80 mm Hg) among 391 patients with Fabry disease who were participating in the Fabry Outcome Survey (FOS). Results Uncontrolled hypertension was present in 57% of men and 47% of women. In patie…

Malemedicine.medical_specialtymedicine.medical_treatmentDiastoleRenal functionBlood PressureKidneyInternal medicinePrevalenceInternal MedicinemedicineHumansSex Ratiocardiovascular diseasesAntihypertensive AgentsKidney transplantationDialysisbusiness.industryEnzyme replacement therapymedicine.diseaseKidney TransplantationFabry diseaseSurgeryBlood pressureHypertensionCardiologyFabry DiseaseFemalebusinessDialysiscirculatory and respiratory physiologyKidney diseaseAmerican Journal of Hypertension
researchProduct

Effects of streptozotocin and dietary fructose on delta-6 desaturation in spontaneously hypertensive rat liver.

2004

We have investigated the effects of hypertension associated with diabetes mellitus on polyunsaturated fatty acid biosynthesis. For this purpose, two rat models for these pathologies have been established: a type 1 diabetic hypertensive model obtained by streptozotocin injection to spontaneously hypertensive rat (SHR), followed or not by insulin treatment (experiment 1); a type 2 diabetic hypertensive model by feeding SHR with a fructose enriched diet (experiment 2). Liver gene expression of delta-6 desaturase (D6D), microsomal D6D activities and fatty acid composition of total lipids were estimated. In experiment 1, an increase of linoleic acid (18:2 n-6) level was observed in the streptozo…

Malemedicine.medical_specialtymedicine.medical_treatmentType 2 diabetesFructoseBiochemistryGene Expression Regulation EnzymologicStreptozocinchemistry.chemical_compoundSpontaneously hypertensive ratInternal medicineDiabetes mellitusMicrosomesRats Inbred SHRmedicineDietary CarbohydratesAnimalsHumansInsulinInsulinFatty AcidsFructoseGeneral Medicinemedicine.diseaseStreptozotocinDietRatsDisease Models AnimalEndocrinologyDiabetes Mellitus Type 1chemistryDiabetes Mellitus Type 2LiverLipogenesisHypertensionFatty Acids UnsaturatedMetabolic syndromeStearoyl-CoA Desaturasemedicine.drugBiochimie
researchProduct

Antihypertensive effects of lactoferrin hydrolyzates: Inhibition of angiotensin- and endothelin-converting enzymes

2013

The potential of bovine lactoferrin (LF) as a source of antihypertensive peptides acting on the renin-angiotensin system (RAS) and the endothelin (ET) system as dual vasopeptidase inhibitors has been examined. For this purpose enzymatic LF hydrolyzates (LFHs) were generated by trypsin and proteinase K digestions. Permeate fractions with molecular masses lower than 3 kDa (LFH <3 kDa) were orally administered to spontaneously hypertensive rats (SHRs). Although both LFHs <3 kDa showed in vitro angiotensin I-converting enzyme (ACE)-inhibitory activity, only proteinase K LFH <3 kDa exerted an in vivo antihypertensive effect. The proteinase K LFH <3 kDa and a previously characterized pepsin LFH <…

Malemedicine.medical_treatmentLactoferrin hydrolyzatesMolecular Sequence DataPeptideAngiotensin-Converting Enzyme InhibitorsBlood PressureIn Vitro TechniquesPeptidyl-Dipeptidase AECE-dependent vasoconstrictionAnalytical ChemistryIn vivoRats Inbred SHRmedicineVasopeptidase InhibitorsAnimalsAmino Acid SequenceAntihypertensive Agentschemistry.chemical_classificationProteasebiologyLactoferrinEndothelinsHydrolysisGeneral MedicineVasopeptidase inhibitorsRenin–angiotensin systemProteinase KTrypsinEndothelin systemRatsLactoferrinEnzymeCarotid ArteriesBiochemistrychemistryVasoconstrictionHypertensionbiology.proteinCattleRabbitsFood Sciencemedicine.drugACE-dependent vasoconstriction
researchProduct

Blood pressure values and depression in hypertensive individuals at high cardiovascular risk

2014

Background: Hypertension and depression are both important risk factors for cardiovascular diseases. Nevertheless, the association of blood pressure on and depression has not been completely established. This study aims to analyze whether depression may influence the control of blood pressure in hypertensive individuals at high cardiovascular risk. Methods: Cross-sectional study, embedded within the PREDIMED clinical trial, of 5954 hypertensive patients with high cardiovascular risk factor profiles. The relationship between blood pressure control and depression was analyzed. A multivariate analysis (logistic and log-linear regression), adjusting for potential confounders (socio-demographic …

Malemodelos logísticoshumanosdepresiónBlood PressureClinical trialsRisk FactorsOdds RatioMedicineDepressió psíquicamediana edadDepression (differential diagnoses)Aged 80 and overancianoantidepresivosDepressionresultado del tratamientomodelos linealesdistribución de la ji al cuadradoMiddle Agedcociente de probabilidades relativasAntidepressive AgentsTreatment OutcomeMental depressionCardiovascular diseasesHypertensionBlood pressureCardiologyHipertensióCardiology and Cardiovascular MedicineResearch Articlepresión sanguíneamedicine.medical_specialtyPressió sanguíniaInternal medicineDiabetes mellitusHumansfactores de riesgoanálisis multifactorialRisk factorAntihypertensive AgentsAgedAngiologyChi-Square DistributionMalalties cardiovascularsbusiness.industryOdds ratiomedicine.diseaseSurgeryCross-Sectional StudiesLogistic ModelsBlood pressureMultivariate AnalysisLinear ModelsantihipertensivoshipertensiónbusinessBody mass indexDyslipidemiaestudios transversalesAssaigs clínicsBMC Cardiovascular Disorders
researchProduct